Technology that could help create paint that can alert people to the presence of a toxin or packaging that changes color with the expiration date of the food inside clearly has potential on the commercial market.
And now two long-time collaborators from Carnegie Mellon University have launched a company designed to take the advancements made possible by polymer-based protein engineering, which was developed at the Pittsburgh university, and enable more companies to use them…
The core of the Biohybrid Solutions™ business is polymer-based protein engineering — essentially a better way of combining proteins and polymers that was developed at CMU. The company aims to improve polymer-protein conjugation by simplifying and automating the process, while also more efficiently removing waste from the final product.
Read more at Pittsburgh Post Gazette.
This story originally appeared in the Pittsburgh Post Gazette on November 8, 2016.
More Company News
Myris Therapeutics is Developing Ultra-High DAR ADCs to Enable Novel Precision Medicine Treatments for Cancer
Myris Therapeutics emerges from stealth to announce new name and strategic focus Proprietary polymer chemistry enables ultra-high drug to antibody ratios of 50 - 100 and new chemical space for precision targeted ADC payloads PITTSBURGH, Feb. 20,...
BioHybrid Solutions Holdings, Inc. Announces Expansion of its Drug Development Leadership
Pittsburgh, PA. June 02, 2023 Biohybrid Solutions Holdings, Inc. (BHS), is a biotechnology company using advanced polymer technologies to address outstanding challenges in the development of biologic drugs. BHS’ NanoArmor® technology balances...
BioHybrid Solutions Holdings, Inc. Appoints Mark Murcko as Board Member
Pittsburgh, PA. August 09, 2022 We are excited to announce the appointment of Mark Murcko, Ph.D., as our newest Board Member. Mark brings over three decades of industry experience, having been at the center of many transformational biotech efforts...